CURRICULUM VITAE Jill Glasspool-Malone, PhD
EMPLOYMENT: Consulting 2001-2005
Co-Founder, Board of Director Member and Secretary of the board
Senior Research Associate
Research Specialist
Research Associate
Staff Research Associate and Animal Health Technician (AHT)
Animal Behaviorist
Zoo Keeper
Behavioral Specialist/Manager.
EDUCATION
ACADEMIC HONORS:
TEACHING EXPERIENCE:
SPECIALITY POST GRADUATE COURSEWORK:
PUBLICATIONS: PEER REVIEWED PAPERS: 1. Glasspool-Malone J. and Malone RW. Methods in Enzymology-Gene Therapy Methods. Enhancing direct in vivo transfection with nuclease inhibitors and pulsed electrical fields. 2002;346:72-91. PMID: 11883098 2. Glasspool-Malone J, et. al., Marked Enhancement of Macaque and Murine Respiratory Tissue Transfection by Aurintricarboxylic Acid. J Gene Med. 2002 May-Jun;4(3):323-2. 3. Drabick, J.J., Glasspool-Malone J., et. al. Increased efficiency of cutaneous transfection and polynucleotide immunization using in-vivo electroporation. Mol Ther 2001 Feb;3(2): 249-255. 4. Somiari S, Glasspool-Malone J, et. al. Theory and in vivo application of electroporative gene delivery. Mol Ther. 2000 Sep;2(3):178-87. 5. Glasspool-Malone J, et. al. Efficient nonviral cutaneous transfection. Mol Ther. 2000 Aug;2(2):140-6. 6. Glasspool-Malone J, Malone RW, "Marked Enhancement of Direct Respiratory Tissue Transfection by Aurintricarboxylic Acid" Human Gene Therapy 1999 Vol 10:10. 7. Berlyn KA, Ponniah S, Stass SA, Malone JG, et. al. Developing Dendritic Cell Polynucleotide Vaccination for Prostate Cancer Immunotherapy. 1999 J. of Biotechnology. 8. Bennett MJ, Aberle AM, Balasubramaniam RP, Malone JG, et. al. Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity. Med Chem 1997 Dec 5;40(25):4069-4078 9. Freedland SJ, Malone RW, Borchers HM, Zadourian Z, Malone JG, et. al. Toxicity of cationic lipid ribozyme in human prostate tumor cells can mimic ribozyme activity. 1997 Biochemical and Molecular Medicine. 10. Malone JG, et. al. Mucosal immune responses associated with polynucleotide vaccination. Behring Institute Research Communications 1997 (No 98). 11. Balasubramaniam RP, Bennet MJ, Aberle AM, Malone JG, et. al. Structural and Functional Analysis of Cationic Transfection Lipids: The Hydrophobic Domain. Gene Therapy 1996 3(2) 163-72. 12. Bennett, M.J., Aberle, A.M., Balasubramaniam, R.P., Malone, J.G., et. al. Considerations for the design of improved cationic amphilphile-based transfection reagents Journal of Liposome Research. 1996. 6(3) 13. A. Aberle, Malone JG, et. al. Structural and Functional Analysis of Cationic Transfection Lipids. M. J. Bennett, R. P. Balasubramaniam, 1995 North American CF Conference, Dallas, Texas, October 12-15. Pediatric Pulmonology. 14. K. D. Bassler, P. Montbriand, M. Bennett, Malone JG, et. al. Genetic Immunization: Effects of Novel Priming and Boosting Strategies. 1995 North American CF Conference, Dallas, Texas, October 12-15. Pediatric Pulmonology. 15. Bennett MJ, Balasubramaniam RP, Bassler KD, Malone JG, et. al. Mechanistic Studies and Cationic Lipid Structure/Function Analysis Leading to Improved Polynucleotide Transfection. Journal of Investigative Medicine, V43 (S2) 330A. 16. Bennett MJ, Aberle AM, Balasubramaniam RP, Malone JG, et. al. PolyGum (TfxTM), a Novel Cationic Liposome Compound Class for use in In Vivo and In Vitro Polynucleotide Delivery. Clinical Chemistry. (1994) 40(12)2341. 17. Killam, K.F., Tarara, E., Malone, J., et. al. (1993) A two year study of cage behavior of monkeys made dependent on morphine and infected with SIV. NIDA Res. Monograph: Problems of Drug Dependence 141:63. ABSTRACTS (selected- Those listed below are published). 18. Efficient rat lung transfection, transplantation and sustained transgene expression by plasmid/ATA electroporation. Schmid RA, Kubisa B, Ayuni E, Cecchini M, Wetterwald A, Glasspool-Malone J, et. al. American Thoracic Society, International Conference. Atlanta, Georgia, USA. May 17-22, 2002 . 19. Electroporation greatly enhances intradermal DNA vaccination. Glasspool-Malone J, et. al. Keystone Sympoisa Conference: Gene-Based Vaccines: Mechanisms, Delivery Systems and Efficacy. Breckenridge, CO April 10-15, 2002. 20. Imaging Gene Transfer distribution and efficiency in Lung. Cecchini M, Malone RW, Kubisa B, Wetterwald A, McDoncald R, Ayuni E, Glasspool-Malone J, et. al. Molecular Imaging in Cancer: Linking Biology, Function, and Clinical Applications In Vivo Lake Buena Vista, FL January 23-27, 2002. 21. Efficiency of cutaneous transfection and genetic immunization is greatly enhanced using in vivo electroporation. Glasspool-Malone J, et. al. International Gene Therapy Conference. Rhodos, Greece. August 6-16, 2000. 22. In vivo electropermealilization of murine and porcine skin enhances transfection efficiency and immunologic responses. Glasspool-Malone J, et. al. American Society of Gene therapy Conference. Denver CO, June 2000 (Selected for Presentation). 23. Increased Efficiency of Cutaneous Transfection Using In Vivo Electroporation in Murine and Porcine Models. Glasspool-Malone J, et. al. Cutaneous Gene Therapy: Problems and Prospects. NIH, Bethesda, MD March 23-24, 2000. (Selected for Presentation). 24. Marked Enhancement of skin Tissue Transfection by Aurintricarboxylic Acid in mice, rats, pigs and macaques. Glasspool-Malone J, et. al. Cutaneous Gene Therapy: Problems and Prospects. NIH, Bethesda, MD March 23-24, 2000. 25. Marked enhancement of direct respiratory tissue transfection by aurintricarboxylic acid (ATA). McDonald RJ, Glasspool-Malone J, et. al. Thirteenth annual Cystic Fibrosis Conference. Seattle, WA. Oct 7-10, 1999. 26. Aurintricarboxylic Acid enhances murine and macaque respiratory tissue transfection, and in vitro analysis indicates inhibition of nucleases is responsible for increased transfection activity. Jill Glasspool-Malone, et. al. Int. Gene Therapy Con. Crete, Greece. August 6-16, 1999. 27. Marked enhancement of direct respiratory tissue transfection by aurintricarboxlic acid. Glasspool-Malone J, et. al. American Society of Gene therapy Conference. Washington, DC June 7-9, 1999. 28. Developing dentritic cell polynucleotide vaccines for lentiviral disease. Malone JG et. al. American Society of Gene therapy Conference. Washington, DC June 7-9, 1999. 29. Feline like dendritic cells-isolation, culture and genetic modifiactions using monocytic precursors. Glasspool-Malone JG, et. al. Symposium on Dendritic Cells in Fundamental and Clinical Immunology. Pittsburgh, PA. September, 24-28, 1998. 30. Zonula Occludens Toxin (Zot) inhibits intracellular trafficking of luciferase DNA in susceptible cells. Watts TL, Malone JG, et. al. Molecular Mechanisms of Transcellular Signaling: From Membrane Receptors to Transcription Factors. Advanced Study Institute Conference sponsored by NATO August, 1998 31. Bennett MJ, Balasubramaniam RP, Aberle A, Crowe LM, Malone JG, et. al. Structural and Functional Analysis of Cationic Transfection Lipids. Cambridge Healthtech Institute's Second Annual Artificial Self-Assembling Systems for Gene Transfer, Boston MA. September 28-29, 1995. 32. Bassler, K.D., S.W. Barnett, P. Montbriand, B. Doe, J.G. Malone, et. al. (1995). Development and testing of intramuscular and mucosal polynucleotide vaccines. 1995 International Symposium on Clinical Immunology, July 20-23, 1995, San Francisco, California. 33. Bassler KD, Montbriand P, Torres JV, Malone JG, et. al. Development and Testing of Intramuscular and Mucosal Genetic Vaccines. American Federation for Clinical Research, Carmel, CA, February 8-11, 1995. 34. Bennett MJ, Aberle AM, Balasubramaniam RP, Malone JG, et. al. PolyGum (Tfx), A Novel Cationic Liposome Compound Class for Use in in vivo and in vitro Polynucleotide Delivery. The Genetic Revolution: The San Diego Conference of the American Association for Clinical Chemistry, Molecular Pathology Division, San Diego, CA, November 17-19, 1994. PRESENTATIONS: Electroporation and intradermal DNA vaccination. Glasspool-Malone J. Keystone Symposia Conference: Gene-Based Vaccines: Mechanisms, Delivery Systems and Efficacy. Breckenridge, CO April 10-15, 2002. PATENTS ISSUED: DNA vaccines for eliciting a mucosal immune response. Malone, RW. and Malone, JG US Pat. Ser. No. 6,110,898 issued 8/29/00. Rights assigned to inventors and negotiations for licensing in progress. PATENTS SUBMITTED: Compounds and Methods for Enhancing Direct In Vivo Gene Transfer. Glasspool-Malone, J and Malone RW. Provisional application filed with US PTO on 8/19/98. Full application filed Feb 14, 1999. National phase entered Feb. 2001. In-vivo Electroporation for eliciting an immune response. Glasspool-Malone J, Drabick, J. and Malone RW. Provisional Patent filed Feb. 2000, full patent filed Feb. 2001. DNA vaccines for eliciting a mucosal immune response. Malone J and Malone RW. Full application filed November, 1999. Continuation of issued patent. PUBLISHED REPORTS: Investment in Research Saves Lives and Money: Facts about Obesity. #6 in a series. Sponsored by Lasker/Funding First. Stacie Propst and Jill Glasspool-Malone. 2003 Investment in Research Saves Lives and Money: Depression. #7 in a series. Sponsored by Lasker/Funding First. Stacie Propst and Jill Glasspool-Malone. 2003 Investment in Research Saves Lives and Money: Facts about COPD. #8 in a series. Sponsored by Lasker/Funding First. Stacie Propst and Jill Glasspool-Malone. 2003 | ||